Delivery Order SPE2DB20D3101-SPE2DB21FK5W7
Award Date
9/21/21
Potential Completion Date
9/22/21
Potential Value
$6.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide Renflexis 100 mg vials to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $6,529.60, is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award is for the delivery of Renflexis 100 mg vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,941.28 fixed-price contract is for the supply of Renflexis 100 mg vials, a specialty medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary...
This federal contract award, valued at $8,257.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Renflexis 100 mg vials, a specialty medication. This award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 100 mg vials of the medication RENFLEXIS. The $1,790.69 fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The award is a delivery order worth $7,501.29 for the supply of the medication Renflexis 100 mg vials. This delivery order is under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of RENFLEXIS 100 MG VIALS. The $3,892.25 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which runs through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,941.94 firm fixed-price delivery order is for the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The award has an ultimate completion date of November 8, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,561.89 firm fixed-price delivery order is for the supply of RENFLEXIS 100 MG VIALS. This award is under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Renflexis 100 mg vials. The contract has a ceiling value of $1,242.50 and runs through December 12, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a...